(-)-Epigallocatechin Gallate (EGCG): Advanced Workflows in C
2026-06-30
(-)-Epigallocatechin gallate (EGCG) is redefining experimental cancer chemoprevention and bone regeneration through its multifaceted antioxidant, antiangiogenic, and antiviral activities. Discover protocol enhancements, troubleshooting tips, and emerging use-cases that place EGCG at the forefront of translational biomedical research.
Triazole ALDH2 Activators Offer New Direction for Myocardial
2026-06-29
A recent study reports the design and evaluation of novel triazole-based activators of aldehyde dehydrogenase 2 (ALDH2) with superior water solubility and unprecedented activation potency. These compounds demonstrated significant protection against myocardial ischemia-reperfusion injury in preclinical models, offering promising avenues for targeted therapy, particularly in genetically susceptible populations.
Entecavir-Associated Thrombocytopenia: Insights from a Rare
2026-06-29
This article reviews a recent case study documenting delayed-onset, severe thrombocytopenia linked to Entecavir therapy in a patient with chronic hepatitis B. The findings highlight a critical, though rare, adverse event, emphasizing the need for vigilant hematological monitoring during long-term Entecavir use and providing guidance for management and future research directions.
ZDHHC4-Mediated Palmitoylation Regulates TRPV1 and Pain Reli
2026-06-28
This study elucidates how the palmitoyl acyltransferase ZDHHC4 mediates S-palmitoylation of TRPV1, promoting its lysosomal degradation and thus facilitating inflammatory pain relief. The findings provide new mechanistic insight into the resolution phase of pain and highlight post-translational modification as a key regulatory axis in nociception.
NP-40 Lysis Buffer: Precision Protein Extraction for Complex
2026-06-27
NP-40 Lysis Buffer empowers researchers to gently lyse diverse cell types—animal, plant, fungal, and bacterial—while preserving native protein interactions, a crucial feature for advanced immunoprecipitation and signaling studies. By enabling reproducible, non-denaturing protein extraction, it streamlines workflows in neuroimmunology and translational research, as highlighted by cutting-edge studies of FPR2/ALX modulation in CNS autoimmunity.
Arrb2-Mediated M2 Macrophage Polarization Mitigates Liver IR
2026-06-26
This study identifies hepatocyte Arrb2 as a key promoter of M2 macrophage polarization through upregulation of the metabolite 6-ketoLCA, resulting in decreased hepatic ischemia–reperfusion injury (IRI). The mechanistic insight offers new avenues for immunomodulatory interventions in liver transplantation.
Kir2.1 Inhibition Suppresses PASMC Proliferation in PH Model
2026-06-26
The reference study establishes Kir2.1 as a key regulator of pulmonary artery smooth muscle cell (PASMC) proliferation and migration in pulmonary hypertension (PH). By inhibiting Kir2.1, notably using ML133, the researchers demonstrate a marked reduction in pathological vascular remodeling, advancing mechanistic understanding and providing a framework for targeted ion channel intervention in PH.
Caspase-4 Colorimetric Assay Kit: Precision in Pyroptosis Re
2026-06-25
The Caspase-4 Colorimetric Assay Kit empowers researchers with rapid, quantitative detection of LEVD-dependent caspase-4 activity, streamlining workflows across inflammation, pyroptosis, and ER stress studies. Its robust performance and reproducible results make it a gold standard for biomarker discovery and signaling pathway analysis.
4-Hydroxytamoxifen: Practical Guide for Laboratory Applicati
2026-06-25
4-Hydroxytamoxifen (SKU B6167) is a high-purity estrogen receptor modulator designed for DMSO-based protocols in breast cancer, prostate cancer, and cardiac myocyte research. It is unsuitable for workflows requiring aqueous or ethanol solubility, and precise storage and handling are essential to maintain reagent integrity and reproducibility.
Cell Counting Kit-8 (CCK-8): Precision Cell Viability Assay
2026-06-24
Cell Counting Kit-8 (CCK-8) delivers sensitive, rapid, and reproducible cell viability measurement using WST-8 chemistry. This kit enables accurate quantification of cell proliferation and cytotoxicity in various in vitro models, outperforming conventional tetrazolium-based assays in sensitivity and ease-of-use.
SVA 3A/2B Proteins Counteract Host DDX23 via Caspase Pathway
2026-06-23
This study reveals how Senecavirus A (SVA) evades host antiviral defense by targeting the DEAD-box helicase DDX23 through its 3A and 2B proteins. By mapping specific caspase-dependent degradation mechanisms, the findings identify new molecular targets for antiviral strategies in veterinary and virology research.
THZ1 (SKU A8882): Reliable Covalent CDK7 Inhibition in T-ALL
2026-06-23
This article provides scenario-driven guidance on deploying THZ1 (SKU A8882), a covalent CDK7 inhibitor, for high-sensitivity transcription regulation and T-ALL research. By leveraging real-world laboratory challenges, we detail how THZ1 ensures reproducible, selective inhibition, supporting robust cell viability and cytotoxicity assays. Researchers are equipped with data-backed strategies and workflow parameters for optimal assay outcomes.
AZD8055: Technical Guidance for mTOR Pathway Inhibition
2026-06-22
AZD8055 is a potent, selective mTOR inhibitor designed for preclinical studies dissecting mTORC1/mTORC2 signaling in cancer biology and metabolism. It is not recommended for studies seeking clinical efficacy endpoints or requiring water solubility. This article provides practical workflow and protocol parameters for researchers using AZD8055.
LDN-193189: ALK Inhibitor Workflows for BMP Pathway Research
2026-06-22
LDN-193189, a potent ALK inhibitor, transforms BMP signaling studies with its nanomolar specificity and operational flexibility across cell and animal models. This article unpacks practical workflows, troubleshooting strategies, and the latest cross-domain applications—empowering researchers to advance epithelial barrier and viral latency research with confidence.
2-(4,5,6,7-tetrabromo...) Inhibitor: A Versatile Small Molec
2026-06-21
The CK2 and ERK8 inhibitor, defined by its unique 2-(4,5,6,7-tetrabromo-2-(dimethylamino)-1H-benzo[d]imidazol-1-yl)acetic acid structure, empowers precise modulation of kinase-driven signaling and phase separation in cell models. Its high purity and robust solubility profile make it a standout biochemical reagent for protein interaction and condensate studies.
466 records 14/32 page Previous Next First page 上5页 1112131415 下5页 Last page